Mechanism of PKM2 affecting cancer immunity and metabolism in Tumor Microenvironment

被引：50

作者：

Chen, Mengxi ^{[1
]}

Liu, Huan ^{[1
]}

Li, Zhang ^{[2
]}

Ming, Alex Lau ^{[2
]}

Chen, Honglei ^{[1
,2
]}

机构：

[1] Wuhan Univ, Dept Pathol, Zhongnan Hosp, Wuhan 430071, Peoples R China

[2] Wuhan Univ, Sch Basic Med Sci, Dept Pathol, Wuhan 430071, Peoples R China

来源：

JOURNAL OF CANCER | 2021年 / 12卷 / 12期

基金：

中国国家自然科学基金;

关键词：

PKM-2; PD-L1; cancer immunity; metabolism; PYRUVATE-KINASE M2; MITOCHONDRIAL DYNAMICS; CELL METABOLISM; MITOFUSIN; ACTIVATION; GLYCOLYSIS; EXPRESSION; SERINE; TRANSCRIPTION; COACTIVATOR;

D O I：

10.7150/jca.54430

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PKM2 is the enzyme that regulates the final rate-limiting step of glycolysis. PKM2 expression can reinforce the utilization of oxygen and synthesis of growth substances in cancer cells by enhancing OXPHOS and the Warburg effect. In cancer immunity, PKM2 can modulate the expression of PD-L1 in M2 macrophage and decrease the amount and activity of CD8(+) T cells. This affects cancer cell killing and immune escape sequentially. How PKM2 regulates PD-L1 expression through immunometabolism is summarized. PKM2 builds a bridge between energy metabolism and cancer immunity. The activator and inhibitor of PKM2 both promote the anti-cancer immune response and inhibit cancer growth and metastasis by regulating the metabolism of cancer cells and immune cells in the tumor microenvironment through HIF-1 alpha/PKM2 pathway. This review focuses on the precise role of PKM2 modulating immunometabolism, providing valuable suggestions for further study in this field.

引用

页码：3566 / 3574

页数：9

共 95 条

[1] Pyruvate kinase activators as a therapy target: a patent review 2011-2017 [J].

Adem, Sevki ;

Comakli, Veysel ;

Uzun, Naim .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28 (01) :61-68

[2] Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells [J].

Albert, ML ;

Jegathesan, M ;

Darnell, RB .

NATURE IMMUNOLOGY, 2001, 2 (11) :1010-1017

[3] Pyruvate kinase M2: A simple molecule with complex functions [J].

Alquraishi, Mohammed ;

Puckett, Dexter L. ;

Alani, Dina S. ;

Humidat, Amal S. ;

Frankel, Victoria D. ;

Donohoe, Dallas R. ;

Whelan, Jay ;

Bettaieb, Ahmed .

FREE RADICAL BIOLOGY AND MEDICINE, 2019, 143 :176-192

[4] Pyruvate Kinase M2: A Potential Target for Regulating inflammation [J].

Alves-Filho, Jose C. ;

Palsson-McDermott, Eva M. .

FRONTIERS IN IMMUNOLOGY, 2016, 7

[5] Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis [J].

Anastasiou, Dimitrios ;

Yu, Yimin ;

Israelsen, William J. ;

Jiang, Jian-Kang ;

Boxer, Matthew B. ;

Hong, Bum Soo ;

Tempel, Wolfram ;

Dimov, Svetoslav ;

Shen, Min ;

Jha, Abhishek ;

Yang, Hua ;

Mattaini, Katherine R. ;

Metallo, Christian M. ;

Fiske, Brian P. ;

Courtney, Kevin D. ;

Malstrom, Scott ;

Khan, Tahsin M. ;

Kung, Charles ;

Skoumbourdis, Amanda P. ;

Veith, Henrike ;

Southall, Noel ;

Walsh, Martin J. ;

Brimacombe, Kyle R. ;

Leister, William ;

Lunt, Sophia Y. ;

Johnson, Zachary R. ;

Yen, Katharine E. ;

Kunii, Kaiko ;

Davidson, Shawn M. ;

Christofk, Heather R. ;

Austin, Christopher P. ;

Inglese, James ;

Harris, Marian H. ;

Asara, John M. ;

Stephanopoulos, Gregory ;

Salituro, Francesco G. ;

Jin, Shengfang ;

Dang, Lenny ;

Auld, Douglas S. ;

Park, Hee-Won ;

Cantley, Lewis C. ;

Thomas, Craig J. ;

Heiden, Matthew G. Vander .

NATURE CHEMICAL BIOLOGY, 2012, 8 (10) :839-847

[6] Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4+ T Cell Pathogenicity and Suppresses Autoimmunity [J].

Angiari, Stefano ;

Runtsch, Marah C. ;

Sutton, Caroline E. ;

Palsson-McDermott, Eva M. ;

Kelly, Beth ;

Rana, Nisha ;

Kane, Harry ;

Papadopoulou, Gina ;

Pearce, Erika L. ;

Mills, Kingston H. G. ;

O'Neill, Luke A. J. .

CELL METABOLISM, 2020, 31 (02) :391-+

[7] Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming [J].

Buck, Michael D. ;

O'Sullivan, David ;

Geltink, Ramon I. Klein ;

Curtis, Jonathan D. ;

Chang, Chih-Hao ;

Sanin, David E. ;

Qiu, Jing ;

Kretz, Oliver ;

Braas, Daniel ;

van der Windt, Gerritje J. W. ;

Chen, Qiongyu ;

Huang, Stanley Ching-Cheng ;

O'Neill, Christina M. ;

Edelson, Brian T. ;

Pearce, Edward J. ;

Sesaki, Hiromi ;

Huber, Tobias B. ;

Rambold, Angelika S. ;

Pearce, Erika L. .

CELL, 2016, 166 (01) :63-76

[8] Serine is a natural ligand and allosteric activator of pyruvate kinase M2 [J].

Chaneton, Barbara ;

Hillmann, Petra ;

Zheng, Liang ;

Martin, Agnes C. L. ;

Maddocks, Oliver D. K. ;

Chokkathukalam, Achuthanunni ;

Coyle, Joseph E. ;

Jankevics, Andris ;

Holding, Finn P. ;

Vousden, Karen H. ;

Frezza, Christian ;

O'Reilly, Marc ;

Gottlieb, Eyal .

NATURE, 2012, 491 (7424) :458-+

[9] Dendritic cell development requires histone deacetylase activity [J].

Chauvistre, Heike ;

Kuestermann, Caroline ;

Rehage, Nina ;

Klisch, Theresa ;

Mitzka, Saskia ;

Felker, Piritta ;

Rose-John, Stefan ;

Zenke, Martin ;

Sere, Kristin M. .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (08) :2478-2488

[10] Disruption of fusion results in mitochondrial heterogeneity and dysfunction [J].

Chen, HC ;

Chomyn, A ;

Chan, DC .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (28) :26185-26192

← 1 2 3 4 5 6 7 8 9 10 →